Vimarsana
Biggest News Aggregation in the World

Bad Ad Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bad Ad Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bad Ad Program Today - Breaking & Trending Today

Hook: Drug advertising - Vimarsana News

Hook: Drug advertising

By Karen L. Kier Pharmacist on behalf of the ONU Healthwise Team In 1991, the film Hook directed by Steven Spielberg was released. The film was the sequel to the 1911 novel Peter & Wendy. The movie starred Robin Williams as Peter Pan, Dustin Hoffman as Captain Hook, and Julia Roberts as Tinkerbell. Jimmy Buffett and David Crosby made cameo appearances as pirates in the movie.

OPDP is Back Sending Untitled Letters after a Yearlong Hiatus | Gardner Law - Vimarsana News

OPDP is Back Sending Untitled Letters after a Yearlong Hiatus | Gardner Law

For a little over a year, the Office of Prescription Drug Promotion (OPDP) sent no untitled letters. OPDP ended this untitled letter hiatus this summer when it sent two untitled...

FDA Issues First Untitled Letter Of The Year To Xeris Pharmaceuticals - Healthcare - Vimarsana News

FDA Issues First Untitled Letter Of The Year To Xeris Pharmaceuticals - Healthcare

The wait is finally over. On June 7, 2023, after remaining silent for over an entire year, the US Food and Drug Administration ("FDA") Office of Prescription Drug Promotion ("OPDP") issued its first untitled...

Source: mondaq.com
FDA Issues First Untitled Letter of the Year to Xeris Pharmaceuticals | Sheppard Mullin Richter & Hampton LLP - Vimarsana News

FDA Issues First Untitled Letter of the Year to Xeris Pharmaceuticals | Sheppard Mullin Richter & Hampton LLP

The wait is finally over. On June 7, 2023, after remaining silent for over an entire year, the US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”)...

FDA Issues First Untitled Letter of the Year to Xeris Pharmaceuticals - Vimarsana News

FDA Issues First Untitled Letter of the Year to Xeris Pharmaceuticals

US FDA OPDP issued first untitled letter of 2023 to Xeris Pharmaceuticals concerning promotional material for Recorlev tablets, citing misleading claims on company webpages.